DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rfnxln/drug_addiction)
has announced the addition of the "Drug
Addiction - Pipeline Review, H2 2014" report to their offering.
http://www.youtube.com/watch?v=ukFjH9odsXw
This report provides comprehensive information on the therapeutic
development for drug addiction, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Drug
Addiction and special features on late-stage and discontinued projects.
This report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information Drug Rehab Cost sourced from proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by This team.
Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Mentioned:
Gilead Sciences, Inc.
Aphios Corporation
Teva Pharmaceutical Industries Limited
Addex Therapeutics Ltd
Biotie Therapies Corp.
Camurus AB
Curemark, LLC
Rottapharm SpA
Omeros Corporation
Immunovaccine, Inc.
Kyorin Pharmaceutical Co., Ltd.
D&A Pharma SAS
Embera NeuroTherapeutics, Inc.
Lightlake Therapeutics Inc.
SK Biopharmaceuticals Co., Ltd.
LondonPharma Ltd
For more information visit http://www.researchandmarkets.com/research/rfnxln/drug_addiction
